Saumen Chakraborty
About Saumen Chakraborty
Data last updated:
Saumen Chakraborty has 13 years in corporate governance. Holds Director and Managing Director roles. Currently with 4 companies, including Granules India Limited and Premas Biotech Private Limited. Formerly with 7 companies, such as Svaas Wellness Limited and Aurigene Oncology Limited. Engaged in General Business, Technology. Contributes to corporate operations. The 4 current companies with reported revenue have a combined latest revenue of ₹9,363 Cr; the largest is Granules India Limited at ₹5,386 Cr (FY 2026).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Granules India Limited L24110TG1991PLC012471 | Director | 13 Dec 2021 | 1991 | ₹5,386 Cr (FY 2026) | Active |
 Krishna Institute Of Medical Sciences Limited L55101TG1973PLC040558 | Director | 08 Jan 2021 | 1973 | ₹3,931 Cr (FY 2026) | Active |
 Premas Biotech Private Limited U24232HR2005PTC035932 | Director | 29 Apr 2022 | 2005 | ₹45.93 Cr (FY 2025) | Active |
 Samarjita Management Consultancy Private Limited U74140TG2020PTC145524 | Managing Director | 03 Nov 2020 | 2020 | ₹0.71 Cr (FY 2025) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Svaas Wellness Limited U85100TG2009PLC064271 | Director | 11 Feb 2013 | 2009 | ₹28.53 Cr (FY 2025) | Active |
 Aurigene Oncology Limited U24239KA2001PLC029391 | Director | 16 Jan 2013 | 2001 | ₹172 Cr (FY 2025) | Active |
| Drl Impex Limited U65990TG1986PLC006695 | Director | 11 Feb 2013 | 1986 | ₹0.39 Cr (FY 2025) | Active |
 Dr. Reddy's Bio-Sciences Limited U72200TG2000PLC034765 | Director | 30 Oct 2013 | 2000 | ₹1.20 Cr (FY 2025) | Active |
| Cheminor Investments Ltd U67120TG1990PLC010931 | Director | 11 Feb 2013 | 1990 | ₹0.19 Cr (FY 2025) | Active |
 Abp Private Limited U22219WB1922PTC004503 | Director | 29 Jun 2017 | 1922 | ₹1,079 Cr (FY 2024) | Active |
| Dr.Reddy's Laboratories Ltd L85195TG1984PLC004507 | Cfo | 13 May 2014 | 1984 | ₹35,059 Cr (FY 2026) | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Saumen Chakraborty
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Saumen Chakraborty
Saumen Chakraborty has 13 years in corporate governance. Holds Director and Managing Director roles. Currently with 4 companies, including Granules India Limited and Premas Biotech Private Limited. Formerly with 7 companies, such as Svaas Wellness Limited and Aurigene Oncology Limited. Engaged in General Business, Technology. Contributes to corporate operations. The 4 current companies with reported revenue have a combined latest revenue of ₹9,363 Cr; the largest is Granules India Limited at ₹5,386 Cr (FY 2026).
Saumen Chakraborty is associated with 4 companies as Director and Managing Director, including Granules India Limited (₹5,386 Cr), Krishna Institute Of Medical Sciences Limited (₹3,931 Cr), Premas Biotech Private Limited (₹45.93 Cr).
Saumen Chakraborty has expertise in General Business, Technology.
Saumen Chakraborty has 13 years in corporate governance.
By reported revenue, the largest current company of Saumen Chakraborty is Granules India Limited, with revenue of ₹5,386 Cr (FY 2026).
The 4 current companies of Saumen Chakraborty that report revenue have a combined latest revenue of ₹9,363 Cr.
Saumen Chakraborty currently holds positions at 4 companies: Granules India Limited (₹5,386 Cr), Krishna Institute Of Medical Sciences Limited (₹3,931 Cr), Premas Biotech Private Limited (₹45.93 Cr), Samarjita Management Consultancy Private Limited (₹0.71 Cr).